NCT00551538View on ClinicalTrials.gov

24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 31, 2003

Study Completion Date

December 31, 2004

Conditions
Type 2 Diabetes
Interventions
DRUG

Lispro mix 75/25

Lispro mix 75/25 twice-daily, SC injection, given in conjunction with oral antidiabetic medications.

DRUG

Glargine

SC injection, once-daily, given in conjunction with oral antidiabetic medications.

Trial Locations (1)

46202

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Indianapolis

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00551538 - 24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine | Biotech Hunter | Biotech Hunter